The medical uses of silver include its use in wound dressings, creams, and as an antibiotic coating on medical devices. Wound dressings containing silver sulfadiazine or silver nanomaterials may be used to treat external infections. The limited evidence available shows that silver coatings on endotracheal breathing tubes may reduce the incidence of ventilator-associated pneumonia. There is tentative evidence that using silver-alloy indwelling catheters for short-term catheterizing will reduce the risk of catheter-acquired urinary tract infections.
Silver generally has low toxicity, and minimal risk is expected when silver is used in approved medical applications.
Silver, used as a topical antiseptic, is incorporated by bacteria it kills. Thus dead bacteria may be the source of silver that may kill additional bacteria.
However systemic reviews in 2014, 2017 and 2018 concluded that more modern treatments, both with and without silver, show better results for wound healing and infection-prevention than silver sulfadiazine, and therefore SSD is no longer generally recommended.
It is on the World Health Organization's List of Essential Medicines. The US Food and Drug Administration (FDA) approved a number of topical preparations of silver sulfadiazine for treatment of second-degree and third-degree burns.
A number of wound dressings containing silver as an anti-bacterial have been cleared by the U.S. Food and Drug Administration (FDA).Ethicon, Inc. "510(k) Summary for K022483". Food and Drug Administration (February 3, 2003). 510(k) "Summary for K023609". Argentum Medical LLC (January 17, 2003). 510(k) "Summary for K050032" Euromed (May 17, 2005). "510(k) Summary for K053627". Kinetic Concepts (February 6, 2006). However, silver-containing dressings may cause staining, and in some cases tingling sensations as well.
The U.S. Food and Drug Administration (FDA) in 2007 cleared an endotracheal tube with a fine coat of silver to reduce the risk of ventilator-associated pneumonia.
A 2017 study found that a combination of chlorhexidine and silver-sulfadiazine (CSS) used to coat central venous catheters (CVC) reduces the rate of catheter-related bloodstream infections. However, they also found that the efficacy of the CSS-CVC coating was progressively eroded by blood-flow, and that the antibacterial function was lost after 48 hours.
Silver nitrate is also used in certain laboratory procedures to stain cells. As it turns them permanently a dark-purple/black color, in doing so increasing individual cells' visibility under a microscope and allowing for differentiation between cells, or identification of irregularities.
Silver is also used in bone prostheses and cardiac devices. In reconstructive hip and knee surgery, silver-coated titanium prostheses are indicated in cases of recalcitrant prosthetic joint infections. Silver diammine fluoride appears to be an effective intervention to reduce dental caries (tooth decay). Silver is also a component in dental amalgam.
Silver acetate has been used as a potential aid to help stop smoking; a review of the literature in 2012, however, found no effect of silver acetate on smoking cessation at a six-month endpoint and if there is an effect it would be small. Silver has also been used in cosmetics, intended to enhance antimicrobial effects and the preservation of ingredients.
One incident of argyria came to the public's attention in 2008, when a man named Paul Karason, whose skin turned blue from using colloidal silver for over 10 years to treat dermatitis, appeared on NBC's Today show. Karason died in 2013 at the age of 62 after a heart attack.Moran, Lee. (2013-09-25) Man who turned blue after taking silver for skin condition dies. Nydailynews.com. Retrieved on 2016-11-26. Another example is Montana politician Stan Jones whose purposeful consumption of colloidal silver was a self-prescribed measure he undertook in response to his fears that the Y2K problem would make antibiotics unavailable, an event that did not occur.
Colloid silver may interact with some prescription medications, reducing the absorption of some antibiotics and thyroxine, among others.
Some people are allergic to silver, and the use of treatments and medical devices containing silver is contraindication for such people. Although medical devices containing silver are widely used in hospitals, no thorough testing and standardization of these products has yet been undertaken.
In August 1999, the U.S. FDA banned colloidal silver sellers from claiming any therapeutic or preventive value for the product, although silver-containing products continue to be promoted as dietary supplements in the U.S. under the looser regulatory standards applied to supplements. The FDA has issued numerous warning letters to Internet sites that have continued to promote colloidal silver as an antibiotic or for other medical purposes. Despite the efforts of the FDA, silver products remain widely available on the market today. A review of websites promoting nasal sprays containing colloidal silver suggested that information about silver-containing nasal sprays on the Internet is misleading and inaccurate. Colloidal silver is also sold in some topical cosmetics, as well as some toothpastes, which are regulated by the FDA as cosmetics (other than drug ingredients making medical claims). "Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)" Food and Drug Administration.
In 2002, the Therapeutic Goods Administration (TGA) found there were no legitimate medical uses for colloidal silver and no evidence to support its marketing claims. The U.S. National Center for Complementary and Integrative Health (NCCIH) warns that marketing claims about colloidal silver are scientifically unsupported, that the silver content of marketed supplements varies widely, and that colloidal silver products can have serious side effects such as argyria.
In 2009, the USFDA issued a consumer advisory warning about the potential adverse effects of colloidal silver, and said that "there are no legally marketed prescription or over-the-counter (OTC) drugs containing silver that are taken by mouth". "Dietary Supplements Containing Silver May Cause Permanent Discoloration of Skin and Mucous Membranes (Argyria)". FDA Consumer Advisory (October 6, 2009). Quackwatch states that colloidal silver dietary supplements have not been found safe or effective for the treatment of any condition. Consumer Reports lists colloidal silver as a "supplement to avoid", describing it as "likely unsafe". The Los Angeles Times stated that "colloidal silver as a cure-all is a fraud with a long history, with quacks claiming it could cure cancer, AIDS, tuberculosis, diabetes, and numerous other diseases".
It may be illegal to market as a preventive or as a treatment for cancer, and in some jurisdictions to sell colloidal silver for consumption. In 2015 an English man was prosecuted and found guilty under the Cancer Act 1939 for selling colloidal silver with claims it could treat cancer.
In 2020, televangelist felon Jim Bakker was sued by the Missouri Attorney General (AG) for marketing colloidal silver products and making false claims about their effectiveness against COVID-19. The Attorney General of New York sent a cease and desist order to Bakker and others about peddling the unproven products that were compared to selling "snake oil", and the Food and Drug Administration also warned Bakker about his actions.
Controversial web show host, podcaster and conspiracy theorist Alex Jones was also warned by the New York Attorney General's office to stop marketing his colloidal silver infused products (toothpaste, mouthwash, dietary supplements, etc.) because he made unproven claims of its ability to fend off COVID-19.
In the 1840s, founder of gynecology J. Marion Sims employed silver wire, which he had a jeweler fashion, as a suture in gynecological surgery. This produced very favorable results when compared with its predecessors, silk and catgut.
Prior to the introduction of modern antibiotics, colloidal silver was used as a Antiseptic and disinfectant. With the development of modern antibiotics in the 1940s, the use of silver as an antimicrobial agent diminished, although it retains some use in medicinal compounds today. Silver sulfadiazine (SSD) is a compound containing silver and the antibiotic sodium sulfadiazine, which was developed in 1968.
Concerns have been expressed about the potential environmental cost of manufactured silver nanomaterials in consumer applications being released into the environment, for example that they may pose a threat to benign soil organisms.
Adverse effects
Water purification
Alternative medicine
Fraudulent products marketed during the COVID-19 outbreak
History
Cost
See also
External links
|
|